Shanghai Zj Bio-Tech Co.Ltd(688317)
Short form equity change report
Name of listed company: Shanghai Zj Bio-Tech Co.Ltd(688317) place of stock listing: Shanghai Stock Exchange Stock abbreviation: Shanghai Zj Bio-Tech Co.Ltd(688317) Stock Code: 688317 information disclosure obligor: Ningbo ruidao venture capital partnership (limited partnership) Address: c0363, zone B, Room 401, building 1, No. 88, Meishan Qixing Road, Beilun District, Ningbo City, Zhejiang Province mailing address: c0363, zone B, Room 401, building 1, No. 88, Meishan Qixing Road, Beilun District, Ningbo City, Zhejiang Province equity change nature: share reduction signing date: February 16, 2022
Statement of information disclosure obligor
1、 This report is prepared by the information disclosure obligor in accordance with the securities law of the people's Republic of China, the measures for the administration of the acquisition of listed companies, the standards for the content and format of information disclosure by companies offering securities to the public No. 15 - Report on changes in equity and other relevant laws and regulations.
2、 The information disclosure obligor has obtained necessary authorization and approval for signing this report, and its performance does not violate or conflict with any provision in the articles of association or internal rules of the information disclosure obligor.
3、 In accordance with the securities law of the people's Republic of China, the measures for the administration of the acquisition of listed companies, and the standards for the contents and forms of information disclosure by companies offering securities to the public No. 15 - Report on changes in equity and other relevant provisions, This report has fully disclosed the changes in shares in which the information disclosure obligor has interests in Shanghai Zj Bio-Tech Co.Ltd(688317) (hereinafter referred to as " Shanghai Zj Bio-Tech Co.Ltd(688317) ", "listed company" and "company"). As of the signing date of this report, except for the information disclosed in this report, the information disclosure obligor has not increased or reduced its shares in Shanghai Zj Bio-Tech Co.Ltd(688317) by any other means.
4、 There are no other additional effective conditions for this equity change. This equity change is based on the information stated in this report. Except for the information disclosure obligor, no unit or individual has been entrusted or authorized to provide the information not listed in this report and make any explanation and explanation to this report.
5、 The information disclosure obligor promises that there are no false records, misleading statements or major omissions in this report, and will bear individual and joint legal liabilities for its authenticity, accuracy and completeness.
catalogue
Section 1 interpretation Section 2 information disclosure obligors Section III purpose of equity change and shareholding plan 8 section 4 equity change method 9 Section 5 trading of shares of Listed Companies in the first six months Section 6 other major matters Section VII declaration of information disclosure obligor Section VIII documents for future reference 13. Short form equity change report fourteen
Section I interpretation
In this report, unless the context otherwise requires, the following abbreviations have the following specific meanings: listed company, company, Zhizhi refers to Shanghai Zj Bio-Tech Co.Ltd(688317) Jiang biological information disclosure obligor, Ningzhi refers to Ningbo ruidao venture capital partnership (limited partnership) Borui Dao
The report and this report refer to the Shanghai Zj Bio-Tech Co.Ltd(688317) simplified equity change report
During the period from February 9, 2022 to February 16, 2022, the information disclosure obligor reduced its holdings of 1079782 shares (accounting for 0.56% of the total share capital of the listed company) through centralized bidding and block trading, Equity change with shareholding ratio less than 5% after reduction.
Shanghai stock exchange refers to Shanghai Stock Exchange
Yuan and 10000 yuan refer to RMB yuan and 10000 yuan
Section 2 information disclosure obligors
1、 Basic information of information disclosure obligor
As of the date of issuance of this report, the basic information of information disclosure obligors is as follows:
Enterprise name: Ningbo ruidao venture capital partnership (limited partnership)
Type of enterprise: limited partnership
Registered address: c0363, zone B, Room 401, building 1, No. 88, Meishan Qixing Road, Beilun District, Ningbo City, Zhejiang Province
Date of establishment: October 9, 2010
Operation period: October 8, 2030
Executive partner Ji Chengwei
Ji Chengwei, the representative appointed by the executive partner
Unified social credit code 913302065630057537
Business scope venture capital (limited to investment in unlisted companies). [for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments]
Mailing address: c0363, zone B, Room 401, building 1, No. 88, Qixing Road, Meishan, Beilun District, Ningbo, Zhejiang
Major partners and capital contributions:
Subscribed capital contribution subscribed capital contribution ratio serial number partner name
(10000 yuan) case (%)
1 Ji Chengwei 473.4 5.26
2 Wang Neng 947.7 10.53
Chapter 3 Junhui 315.9 3.51
4 Chen Mei 315.9 3.51
5 Sun Lihua 552.6 6.14
6 Zhang Ying 315.9 3.51
7 Xu Manping 158.4 1.76
8 Ni Yuhua 315.9 3.51
9 Ding Xiaomei 474.3 5.27
10 Deng Jianhua 205.2 2.28
11 Qiu Jianyi 236.7 2.63
12 Zhang Huiyan 711 7.9
13 Lujie 347.4 3.86
14 Peng Jianmin 315.9 3.51
15 Ye Feng 789.3 8.77
16 Wang binyuan 315.9 3.51
17 Shen Yu 395.1 4.39
18.395.1 4.39
19 Zhang Ying 144 1.6
20 Wu Xiaoling 360 4
21 Xu Ying 914.4 10.16
Total - 9000 100
Note: the discrepancy between the total and the mantissa of the sum of the sub item values is caused by rounding.
2、 Information about the principal of the information disclosure obligor
The main persons in charge of the information disclosure obligor are as follows:
Whether long-term residence has obtained the name, gender, position and nationality of other countries
Right of abode in place or region
Ji Chengwei male executive partnership Hangzhou, China no
people
3、 Shares of other listed companies owned by information disclosure obligors
As of the signing date of this report, the information disclosure obligor does not hold shares of other domestic and overseas listed companies with interests up to or exceeding 5% of the issued shares of the company.
Section III purpose of equity change and shareholding plan
1、 Purpose of this equity change
The reason for this equity change is that the business operation of the information disclosure obligor needs to reduce the shares of the listed company.
2、 Shareholding plan of information disclosure obligor in the next 12 months
1. The company disclosed the announcement of Shanghai Zj Bio-Tech Co.Ltd(688317) shareholders' share reduction plan through centralized bidding (Announcement No.: 2022-003) on January 18, 2022. Ningbo ruidao plans to reduce no more than 1947040 shares of the company through centralized bidding, and the reduction period is within three months after 15 trading days from the date of disclosure of the announcement.
2. As of the signing date of this report, Ningbo Rui has implemented the above reduction plan.
3. As of the signing date of this report, the information disclosure obligor will reduce its shares of the company through centralized bidding in the next 12 months according to the above reduction plan according to market conditions, stock price and other factors. In addition to the above reduction plan, as of the signing date of this report, the information disclosure obligor does not rule out the possibility of continuing to reduce the shares of the listed company on the basis of complying with and complying with the current effective laws, regulations and normative documents in the next 12 months. In case of relevant equity changes, the information discloser will perform the obligation of information disclosure in strict accordance with relevant regulations.
Section IV changes in equity
1、 Number and proportion of shares owned by the information disclosure obligor in the listed company
Before this equity change, Ningbo ruidao held 10814800 Shanghai Zj Bio-Tech Co.Ltd(688317) non tradable shares, accounting for 5.55% of the total share capital of the company, and was a shareholder holding more than 5% of the company. After this equity change, as of the signing date of this report, Ningbo ruidao holds 9735018 shares, all of which are non tradable shares, accounting for 4.99% of the total share capital of the company.
2、 Changes in equity this time
In this equity change, the details of the equity change of the information disclosure obligor are as follows:
Shareholder's name reduction method change time price range reduction of shares in total share capital (yuan / share) (share)
Ningbo ruidao block trading 20
